Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Ascelia Pharma

3.43 SEK

+11.18 %

Less than 1K followers

ACE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Ascelia Pharma

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue
EBITDA-17.8-21.9-67.8-20.3-23.0-15.3-15.8-74.4
EBIT-17.8-21.9-67.8-20.3-23.0-15.3-15.8-74.4
EBIT-%
Profit before taxes-21.8-28.4-80.1-21.9-23.2-15.7-15.9-76.7
Net income-21.7-28.3-80.0-21.7-23.0-15.7-15.9-76.3
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.